USAID supported SAMRIDH offers funding of $27million for COVID Crisis, Health News, ET HealthWorld

New Delhi: To address the challenges forged by second wave of COVID-19, the U.S. Agency for International Development (USAID) supported SAMRIDH Healthcare Blended Financing Facility is offering a emergency funding of worth $27 million to healthcare enterprises for the production and supply of high impact health solutions.

This fund will be available to support solutions that are aligned with national health priorities, such as oxygen delivery systems, cold chain storage for vaccines, supply chain management for pharmaceuticals, training for healthcare workers, and other facility and community-based interventions, and can be rapidly scaled to address COVID-19 and subsequent health crisis.

SAMRIDH works in technical collaboration with premier institutions, such as the Indian Institute of Technology-Delhi, the Principal Scientific Advisor to the Government of India, the National Health Authority, and NATHEALTH, mobilizing financial assistance to healthcare enterprises and innovators to support scaling up of market-based health solutions.

SAMRIDH is led and implemented by a Technical Support Unit, managed by IPE Global.

Elucidating on this support, USAID India Health Office Director, Sangita Patel, said: “This additional funding to SAMRIDH reflects USAID’s strong commitment to support high impact market solutions to accelerate India’s response to the COVID-19 pandemic. Through SAMRIDH, we fast-track our efforts
View More USAID supported SAMRIDH offers funding of $27million for COVID Crisis, Health News, ET HealthWorld